Cargando…
Biomaterials promote in vivo generation and immunotherapy of CAR-T cells
Chimeric antigen receptor-T (CAR-T) cell therapy based on functional immune cell transfer is showing a booming situation. However, complex manufacturing processes, high costs, and disappointing results in the treatment of solid tumors have limited its use. Encouragingly, it has facilitated the devel...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157406/ https://www.ncbi.nlm.nih.gov/pubmed/37153571 http://dx.doi.org/10.3389/fimmu.2023.1165576 |